China NMPA Product Recall - Nasal mucosal atomizing spray drug delivery device

The National Medical Products Administration (NMPA) issued a notice on December 5, 2016, concerning a global voluntary recall initiated by Wolfe Tory Medical, Inc., for its Nasal Nebulizer Spray Devices. The recall was prompted by reports indicating that affected product batches failed to produce a nebulized spray, instead emitting a direct current. This critical malfunction could significantly compromise the intended efficacy of medications delivered through the device, potentially leading to serious injury or death in emergency medical scenarios requiring precise drug administration, such as anesthesia, hypoglycemia reversal, or seizure treatment. While Wolfe Tory Medical Devices Trading (Shanghai) Co., Ltd. is the registered distributor, the manufacturer confirmed that the recalled devices (Registration Certificate No.: CFDA (Imported) 2013 No. 2665110) were not imported into or sold within mainland China. Consequently, no specific corrective actions were required from Chinese regulatory bodies concerning products in the Chinese market. However, provincial and municipal food and drug administration departments were instructed to maintain supervisory oversight over such products. The recall report, submitted by Teleflex MEDICAL, detailed the issue on November 3, 2016, emphasizing the potential for adverse health consequences due to the device's functional defect.